BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33878349)

  • 41. Performance of additional colonoscopies and yield of neoplasms within 3 years after screening colonoscopy: a historical cohort study.
    Stock C; Hoffmeister M; Birkner B; Brenner H
    Endoscopy; 2013 Jul; 45(7):537-46. PubMed ID: 23801314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy.
    Avidan B; Sonnenberg A; Schnell TG; Leya J; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Jun; 97(6):1524-9. PubMed ID: 12094877
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
    Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Underuse and Overuse of Colonoscopy for Repeat Screening and Surveillance in the Veterans Health Administration.
    Murphy CC; Sandler RS; Grubber JM; Johnson MR; Fisher DA
    Clin Gastroenterol Hepatol; 2016 Mar; 14(3):436-444.e1. PubMed ID: 26492843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Participation and yield of a population-based colorectal cancer screening programme in China.
    Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
    Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of advanced colonic neoplasm in symptomatic patients: a scoring system to prioritize colonoscopy (COLONOFIT study).
    Fernández-Bañares F; Clèries R; Boadas J; Ribes J; Oliva JC; Alsius A; Sanz X; Martínez-Bauer E; Galter S; Pujals M; Pujol M; Del Pozo P; Campo R
    BMC Cancer; 2019 Jul; 19(1):734. PubMed ID: 31345180
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study.
    Brenner H; Hoffmeister M; Arndt V; Stegmaier C; Altenhofen L; Haug U
    J Natl Cancer Inst; 2010 Jan; 102(2):89-95. PubMed ID: 20042716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals.
    Sekiguchi M; Kakugawa Y; Matsumoto M; Matsuda T
    J Gastroenterol; 2018 Oct; 53(10):1109-1119. PubMed ID: 29359244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of a colonoscopic screening programme in first-degree relatives of patients with colorectal cancer.
    Puente Gutiérrez JJ; Marín Moreno MA; Domínguez Jiménez JL; Bernal Blanco E; Díaz Iglesias JM
    Colorectal Dis; 2011 Jun; 13(6):e145-53. PubMed ID: 21564467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening.
    Kahi CJ; Anderson JC; Waxman I; Kessler WR; Imperiale TF; Li X; Rex DK
    Am J Gastroenterol; 2010 Jun; 105(6):1301-7. PubMed ID: 20179689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
    Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
    Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The first 2 years of colorectal cancer screening in Ferrara, Italy.
    Matarese VG; Feo CV; Lanza G; Fusetti N; Carpanelli MC; Cataldo S; Cifalà V; Ferretti S; Gafà R; Marzola M; Montanari E; Palmonari C; Simone L; Trevisani L; Stockbrugger R; Gullini S
    Eur J Cancer Prev; 2011 May; 20(3):166-8. PubMed ID: 21445018
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of a quarterly report card on colonoscopy quality measures.
    Kahi CJ; Ballard D; Shah AS; Mears R; Johnson CS
    Gastrointest Endosc; 2013 Jun; 77(6):925-31. PubMed ID: 23472996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions.
    Wong MC; Ching JY; Chiu HM; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Ng SC; Wu JC; Chan FK; Sung JJ
    Am J Gastroenterol; 2016 Nov; 111(11):1621-1629. PubMed ID: 26977757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colonoscopy findings in high-risk individuals compared to an average-risk control population.
    Forsberg A; Kjellström L; Andreasson A; Jaramillo E; Rubio CA; Björck E; Agréus L; Talley NJ; Lindblom A
    Scand J Gastroenterol; 2015 Jul; 50(7):866-74. PubMed ID: 25762374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years.
    Laiyemo AO; Murphy G; Albert PS; Sansbury LB; Wang Z; Cross AJ; Marcus PM; Caan B; Marshall JR; Lance P; Paskett ED; Weissfeld J; Slattery ML; Burt R; Iber F; Shike M; Kikendall JW; Lanza E; Schatzkin A
    Ann Intern Med; 2008 Mar; 148(6):419-26. PubMed ID: 18347350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proposal of high-risk adenoma detection rate as an impactful, complementary quality indicator of colonoscopy.
    Wadhwa V; Jobanputra Y; Al Taii H; Thota PN; Lopez R; Gurudu SR; Sanaka MR
    Surg Endosc; 2020 Jan; 34(1):325-331. PubMed ID: 30927122
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
    Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
    Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.